
    
      A randomized, double-blind, multicenter, allopurinol-controlled and parallel-assigned study
      comparing 40 mg, 80 mg of febuxostat, and allopurinol 300 mg in subjects with gout. Subjects
      will receive treatment for 24 weeks.
    
  